Cases & Deals

King Pharmaceuticals launches patent infringement action regarding Avinza®

Clients King Pharmaceuticals, Inc.

Jones Day represents King Pharmaceuticals, Inc. in a Paragraph IV patent infringement litigation involving generic Morphine Sulfate Extended-Release Capsules USP for 30, 60, 90 and 120 mg doses.

King Pharmaceuticals Inc. et al v. Actavis, Inc. et al (2-09-cv-06585) NJD